Semaglutide met both primary endpoints in part 1 of ESSENCE. Topline results were announced from part 1 of a phase 3 clinical trial evaluating subcutaneous semaglutide in patients with metabolic ...

Semaglutide was compared to 7 other antidiabetic medications in 7 target trials emulated among 1,094,761 eligible patients with type 2 diabetes without a prior AD diagnosis. HealthDay News — For ...

Semaglutide linked to significantly reduced risk, most strongly compared with insulin and most weakly with other GLP-1 RAs. HealthDay News — For patients with type 2 diabetes mellitus ...

In the ESSENCE trial, semaglutide improved liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis (MASH). Two separate phase 3 trials show that semaglutide improved fatty ...

By Kim Masters Editor-at-Large I had not seen or spoken to Jon in the more than 25 years since the publication of Hit & Run, the book that Nancy Griffin and I wrote about Sony’s ill-advised 1989 ...

EDMONTON, Alberta, Canada – Derrick Lewis thinks Jon Jones makes quick work of Stipe Miocic. Jones (27-1 MMA, 21-1 UFC) defends his heavyweight title against former champion Miocic (20-4 MMA, 14-4 UFC ...

In the phase 3 Essence trial, a once-weekly dose of semaglutide 2.4 mg helped to improve liver fibrosis with no worsening of steatohepatitis and to resolve steatohepatitis with no worsening of ...

Jon Jones was just 23 years old when he became UFC light heavyweight champion in 2011, making him the youngest belt holder in the fight promotion's three-decade history. He looked unbeatable and ...

The bench trial for UFC heavyweight champion Jon Jones took place Tuesday in Bernalillo County court in Albuquerque, N.M., with an agreement reached between the defense and prosecutors for dismissal ...

Jon Stewart is defending a controversial comic at Donald Trump’s Madison Square Garden event who compared Puerto Rico to a “floating pile of garbage,” casting blame on the former president ...